X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs MERCK LTD - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA MERCK LTD SANOFI INDIA/
MERCK LTD
 
P/E (TTM) x 30.7 26.1 117.9% View Chart
P/BV x 5.4 2.9 185.9% View Chart
Dividend Yield % 1.7 1.0 171.5%  

Financials

 SANOFI INDIA   MERCK LTD
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
MERCK LTD
Dec-16
SANOFI INDIA/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs4,5601,060 430.2%   
Low Rs4,400623 706.3%   
Sales per share (Unadj.) Rs1,028.5632.4 162.6%  
Earnings per share (Unadj.) Rs129.045.7 282.1%  
Cash flow per share (Unadj.) Rs186.062.3 298.5%  
Dividends per share (Unadj.) Rs68.0011.00 618.2%  
Dividend yield (eoy) %1.51.3 116.1%  
Book value per share (Unadj.) Rs753.6388.8 193.8%  
Shares outstanding (eoy) m23.0316.60 138.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.41.3 327.4%   
Avg P/E ratio x34.718.4 188.7%  
P/CF ratio (eoy) x24.113.5 178.4%  
Price / Book Value ratio x5.92.2 274.7%  
Dividend payout %52.724.1 219.1%   
Avg Mkt Cap Rs m103,17413,969 738.6%   
No. of employees `0003.61.6 228.9%   
Total wages/salary Rs m3,5921,487 241.6%   
Avg. sales/employee Rs Th6,537.76,631.9 98.6%   
Avg. wages/employee Rs Th991.4939.2 105.6%   
Avg. net profit/employee Rs Th819.8479.4 171.0%   
INCOME DATA
Net Sales Rs m23,68610,498 225.6%  
Other income Rs m708242 292.1%   
Total revenues Rs m24,39410,741 227.1%   
Gross profit Rs m5,2811,135 465.2%  
Depreciation Rs m1,313276 476.6%   
Interest Rs m150-   
Profit before tax Rs m4,6611,102 422.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,691343 492.6%   
Profit after tax Rs m2,970759 391.4%  
Gross profit margin %22.310.8 206.2%  
Effective tax rate %36.331.1 116.5%   
Net profit margin %12.57.2 173.5%  
BALANCE SHEET DATA
Current assets Rs m15,6736,410 244.5%   
Current liabilities Rs m6,6788,828 75.6%   
Net working cap to sales %38.0-23.0 -164.8%  
Current ratio x2.30.7 323.3%  
Inventory Days Days7658 131.7%  
Debtors Days Days2238 58.1%  
Net fixed assets Rs m8,0981,406 575.8%   
Share capital Rs m230166 138.7%   
"Free" reserves Rs m17,0886,286 271.8%   
Net worth Rs m17,3566,455 268.9%   
Long term debt Rs m00-   
Total assets Rs m25,4008,828 287.7%  
Interest coverage x311.7NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.91.2 78.4%   
Return on assets %11.88.6 136.7%  
Return on equity %17.111.8 145.5%  
Return on capital %26.917.1 157.8%  
Exports to sales %24.58.3 295.7%   
Imports to sales %28.021.0 133.0%   
Exports (fob) Rs m5,801869 667.2%   
Imports (cif) Rs m6,6272,209 300.0%   
Fx inflow Rs m7,145959 745.2%   
Fx outflow Rs m6,8462,612 262.1%   
Net fx Rs m299-1,653 -18.1%   
CASH FLOW
From Operations Rs m3,2261,070 301.4%  
From Investments Rs m-1,555-750 207.4%  
From Financial Activity Rs m-1,818-150 1,213.6%  
Net Cashflow Rs m-147171 -86.0%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 51.8 116.6%  
Indian inst/Mut Fund % 14.4 18.2 79.1%  
FIIs % 14.6 1.0 1,460.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 29.1 36.1%  
Shareholders   15,184 28,591 53.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  AJANTA PHARMA  UNICHEM LAB  

Compare SANOFI INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 17, 2017 03:37 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - STERLING BIOTECH COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS